Clincosm LogoSign in Get a demo

lymphoma

Showing 26 - 50 of 1,788
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Communication Training Intervention for Large B-Cell Lymphoma

Recruiting
  • Lymphoma, B-Cell
  • +5 more
  • Hematolo-GIST Training
  • Participants Appointment
  • New York, New York
  • +2 more
Jul 3, 2023

Lymphoma Trial (Ultra Low Dose 4 Gy Radiation)

Not yet recruiting
  • Lymphoma
  • Ultra Low Dose 4 Gy Radiation
  • (no location specified)
Jun 30, 2023

HIV, Lymphoma Trial in Zhanjiang (KL-7SHRNA injection solution)

Recruiting
  • HIV Infections
  • Lymphoma
  • KL-7SHRNA injection solution
  • Zhanjiang, Guangdong, China
    Affiliated hospital of Guangdong medical university
Jun 24, 2023

Breast Cancer, Lymphoma Trial in Oklahoma City (PARASYM TENS unit, PARASYM TENS unit (Placebo))

Not yet recruiting
  • Breast Cancer
  • Lymphoma
  • PARASYM TENS unit
  • PARASYM TENS unit (Placebo)
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Jun 26, 2023

Extranodal Lymphoma or Lymphoma of Rare Pathological Types

Not yet recruiting
  • Lymphoma
  • +8 more
  • No interventions need to be specified for this study
  • Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
Jun 15, 2023

Breast Cancer, Stage 0, Colorectal Cancer Stage I, Head Neck Cancer Stage I Trial (CaRE@Home intervention)

Not yet recruiting
  • Breast Cancer, Stage 0
  • +11 more
  • CaRE@Home intervention
  • (no location specified)
Jun 9, 2023

Lymphoma-associated Hemophagocytic Lymphohistiocytosis

Recruiting
  • Lymphoma
  • Hemophagocytic Lymphohistiocytoses
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jun 1, 2023

    Chemotherapeutic Toxicity, Cardiotoxicity, Heart Failure Trial in Tainan (Prevention therapy, Rescue therapy)

    Recruiting
    • Chemotherapeutic Toxicity
    • +4 more
    • Prevention therapy
    • Rescue therapy
    • Tainan, Taiwan
      National Cheng Kung University Hospital
    Jun 6, 2023

    Lymphoma Trial in Yerevan (Balstilimab)

    Not yet recruiting
    • Lymphoma
    • Yerevan, Armenia
      Hematology Center named after prof. R. Yeolyan
    May 26, 2023

    Advanced Solid Tumor, Lymphoma Trial in India, United States (GRC 54276, GRC 54276 + Pembrolizumab, GRC 54276 + Atezolizumab)

    Recruiting
    • Advanced Solid Tumor
    • Lymphoma
    • GRC 54276
    • +2 more
    • Milwaukee, Wisconsin
    • +7 more
    May 26, 2023

    Treatment With Steroids and PEG- Asparaginase in Children and

    Recruiting
    • Precursor Cell Lymphoblastic Leukemia-Lymphoma
    • +3 more
      • Aarhus N, Denmark
        Aarhus University Hospital
      May 15, 2023

      Musculoskeletal Health in Adult Haematological Cancer Survivors

      Not yet recruiting
      • Lymphoma
      • +3 more
      • Not an intervention study
      • (no location specified)
      May 9, 2023

      Solid Tumor, Lymphoma Trial in Lyon (Multidisciplinary day hospitalization)

      Recruiting
      • Solid Tumor
      • Lymphoma
      • Multidisciplinary day hospitalization
      • Lyon, France
        Centre Leon Berard
      May 11, 2023

      Selinexor-based Regimens for Treatment of Non-Hodgkin Lymphoma

      Recruiting
      • Lymphoma
      • +2 more
      • Shanghai, Shanghai, China
      • +2 more
      May 9, 2023

      Lymphoma Trial in Changchun (PEG-rhG-CSF, RhG-CSF)

      Not yet recruiting
      • Lymphoma
      • Changchun, Jilin, China
        The First Bethune Hospital of Jilin University
      Apr 18, 2023

      Lymphoma Trial in Cairo (BEAM Protocol, CEM protocol)

      Recruiting
      • Lymphoma
      • BEAM Protocol
      • CEM protocol
      • Cairo, Egypt
        International Medical Center (IMC) Hospital, Cairo, Egypt.
      Apr 1, 2023

      Lymphoma, Lymphoma, Large B-Cell, Diffuse Trial in Boston (Glofitamab, Polatuzumab, Rituximab)

      Not yet recruiting
      • Lymphoma
      • Lymphoma, Large B-Cell, Diffuse
      • Boston, Massachusetts
      • +1 more
      Apr 4, 2023

      Hematologic Malignancy, Lymphoma Trial (Home-based training, Center-based training)

      Not yet recruiting
      • Hematologic Malignancy
      • Lymphoma
      • Home-based training
      • Center-based training
      • (no location specified)
      Mar 20, 2023

      PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)

      Not yet recruiting
      • PD-1 Antibody
      • +3 more
      • L-DEP and PD-1 antibody
      • Beijing, Beijing, China
        Beijing Friendship Hospital, Capital Medical University
      Mar 8, 2023

      Solid Tumor, Haematological Malignancy, Malignant Tumor Trial in United Kingdom (Alectinib)

      Recruiting
      • Solid Tumor
      • +10 more
      • Belfast, United Kingdom
      • +25 more
      Mar 14, 2023

      Lymphoma, Leukemia, Myeloma Trial in Tampa (Resistance Training, Aerobic Exercise)

      Recruiting
      • Lymphoma
      • +2 more
      • Resistance Training
      • Aerobic Exercise
      • Tampa, Florida
        Moffitt Cancer Center
      Feb 28, 2023

      SUper-Resolution Ultrasound Imaging of Erythrocytes in Normal

      Recruiting
      • Head and Neck Cancer
      • +2 more
      • Malignant lymph nodes
      • Copenhagen, Capital Region, Denmark
      • +1 more
      Mar 3, 2023

      Solid Advanced Tumor, Lymphoma Trial in Belgium, France (OSE-279 100mg, OSE-279 300mg, OSE-279 500mg)

      Recruiting
      • Solid Advanced Tumor
      • Lymphoma
      • OSE-279 100mg
      • +2 more
      • Anderlecht, Belgium
      • +5 more
      Feb 27, 2023

      Leukemia, Lymphoma, Myeloma Trial in Miami, Chicago, San Antonio (LLS Program)

      Not yet recruiting
      • Leukemia
      • +4 more
      • LLS Program
      • Miami, Florida
      • +2 more
      Feb 16, 2023

      Lymphoma Trial (BYON4228 + Rituximab)

      Not yet recruiting
      • Lymphoma
      • BYON4228 + Rituximab
      • (no location specified)
      Feb 20, 2023